The UK is seeing a growing interest in mind-altering compounds , particularly N,N-Dimethyltryptamine and this lesser-known cannabinoid. Investigators are steadily studying the potential of these compounds for medical purposes, resulting in a nuanced discussion around their ethical status and safe